JACC. Advances · 2025
Direct Comparison of 67Ga-Scintigraphy and Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Cardiac Sarcoidosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kurashima Shinichi, Kitai Takeshi, Nabeta Takeru, Naruse Yoshihisa, Taniguchi Tatsunori, Miyakoshi Chisato, Miyoshi Yutaro, Tanaka Hidekazu, Morimoto Ryota, Baba Yuichi, Furukawa Yutaka, Matsue Yuya, Izumi Chisato
Аннотация
BACKGROUND: 67Ga scintigraphy and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) are useful tools for diagnosing cardiac sarcoidosis (CS). However, its comparative diagnostic and prognostic values remain unclear.
OBJECTIVES: This study aimed to assess the positivity rates, clinical characteristics, and prognosis of patients with CS who underwent both 67Ga scintigraphy and FDG-PET.
METHODS: We retrospectively studied 512 patients with CS who were enrolled in the ILLUMINATE-CS (ILLUstration of the Management and prognosIs of JapaNese PATiEnts with CS) registry. Among them, 101 patients who underwent both 67Ga scintigraphy and FDG-PET before immunosuppressive drug administration were analyzed. Myocardial segments showing uptake on 67Ga scintigraphy and FDG-PET/computed tomography were semiquantified using the American Heart Association's 17-segment model.
RESULTS: The median age was 63 (56-70) years, 64 (63.4%) patients were female, and the median left ventricular ejection fraction was 48 (38-59)%. The patients were divided into 4 groups based on the findings of both examinations: 1) both-positive (n = 26, 25.7%); 2) only FDG-PET-positive (n = 72, 71.3%); 3) only 67Ga scintigraphy-positive (n = 0, 0%); and 4) both-negative (n = 3, 3.0%). Among the FDG-PET-positive patients, only 26 (26.5%) showed uptake on 67Ga scintigraphy. Conversely, 94.0% of the segments that showed uptake on 67Ga scintigraphy were also identified as positive segments on FDG-PET. During a median follow-up of 2.9 (1.4-5.3) years, the composite outcome of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia showed no significant difference between patients in the both-positive group and those in the only FDG-PET positive group.
CONCLUSIONS: 67Ga scintigraphy demonstrates lower sensitivity for detecting myocardial inflammation in CS than FDG-PET and has limited prognostic significance.
OBJECTIVES: This study aimed to assess the positivity rates, clinical characteristics, and prognosis of patients with CS who underwent both 67Ga scintigraphy and FDG-PET.
METHODS: We retrospectively studied 512 patients with CS who were enrolled in the ILLUMINATE-CS (ILLUstration of the Management and prognosIs of JapaNese PATiEnts with CS) registry. Among them, 101 patients who underwent both 67Ga scintigraphy and FDG-PET before immunosuppressive drug administration were analyzed. Myocardial segments showing uptake on 67Ga scintigraphy and FDG-PET/computed tomography were semiquantified using the American Heart Association's 17-segment model.
RESULTS: The median age was 63 (56-70) years, 64 (63.4%) patients were female, and the median left ventricular ejection fraction was 48 (38-59)%. The patients were divided into 4 groups based on the findings of both examinations: 1) both-positive (n = 26, 25.7%); 2) only FDG-PET-positive (n = 72, 71.3%); 3) only 67Ga scintigraphy-positive (n = 0, 0%); and 4) both-negative (n = 3, 3.0%). Among the FDG-PET-positive patients, only 26 (26.5%) showed uptake on 67Ga scintigraphy. Conversely, 94.0% of the segments that showed uptake on 67Ga scintigraphy were also identified as positive segments on FDG-PET. During a median follow-up of 2.9 (1.4-5.3) years, the composite outcome of all-cause death, hospitalization for heart failure, and fatal ventricular arrhythmia showed no significant difference between patients in the both-positive group and those in the only FDG-PET positive group.
CONCLUSIONS: 67Ga scintigraphy demonstrates lower sensitivity for detecting myocardial inflammation in CS than FDG-PET and has limited prognostic significance.